↓ Skip to main content

Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma

Overview of attention for article published in Frontiers in immunology, November 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
5 X users

Citations

dimensions_citation
90 Dimensions

Readers on

mendeley
111 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma
Published in
Frontiers in immunology, November 2018
DOI 10.3389/fimmu.2018.02551
Pubmed ID
Authors

Kerry S. Campbell, Adam D. Cohen, Tatiana Pazina

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 111 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 22 20%
Researcher 18 16%
Student > Bachelor 10 9%
Other 8 7%
Student > Doctoral Student 7 6%
Other 11 10%
Unknown 35 32%
Readers by discipline Count As %
Medicine and Dentistry 19 17%
Immunology and Microbiology 16 14%
Biochemistry, Genetics and Molecular Biology 11 10%
Agricultural and Biological Sciences 7 6%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Other 14 13%
Unknown 39 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 November 2018.
All research outputs
#15,890,477
of 25,604,262 outputs
Outputs from Frontiers in immunology
#15,574
of 32,042 outputs
Outputs of similar age
#203,807
of 365,662 outputs
Outputs of similar age from Frontiers in immunology
#416
of 739 outputs
Altmetric has tracked 25,604,262 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 32,042 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,662 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 739 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.